Hav Vaccines
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
11 Parkside Ave, London, Greater London,...Phone Number
+44 1481234345Website
www.hav-vaccines.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Hav Vaccines
HAV Vaccines Ltd (HVL) was established in London in 2009. Our primary objective is the development and commercialisation of a modern, virally vectored T-cell vaccine for the treatment of Crohn's disease (CD) and support for the development of a novel companion diagnostic. A secondary objective is the development of a similar vaccine to treat Johne's disease (JD) in farm animals. The vaccine is designed to attenuate and eradicate chronic infection caused by Mycobacterium avium subspecies paratuberculosis (MAP), a pathogen that is known to cause JD and believed to have a pivotal role in the causation of CD. It has been developed during 10 years of pioneering research by Prof Hermon-Taylor and his team at St Georges Medical School/University of London and Kings College London with funding provided by research grants and a large number of donations from CD patients and their families and friends during that time. HVL's anti-MAP vaccine has since successfully completed its pre-clinical deveRead more
Hav Vaccines Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Hav Vaccines your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Hav Vaccines had a recent Job posting/layoffs
Earning: See what the market has to say on Hav Vaccines recently announced quarterly report
Hav Vaccines, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Hav Vaccines has new funding data
Check out if Hav Vaccines is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Hav Vaccines
Website visits: Recent activity has been detected on your website
Check if Hav Vaccines has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Hav Vaccines launches new products
Recommended Actions
Reach out to Masked Content who joined Hav Vaccines as Masked Content
Find more new buyers
Compare Similar Companies to Hav Vaccines
Compare insights from companies similar to Hav Vaccines, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Hav Vaccines is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Hav Vaccines is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Hav Vaccines.
Hav Vaccines Tech Stack
A closer look at the technologies used by Hav Vaccines
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Hav Vaccines
Sign Up For FreeTo access detailed company insights
HAV Vaccines Ltd (HVL) was established in London in 2009. Our primary objective is the development and commercialisation of a modern, virally vectored T-cell vaccine for the treatment of Crohn's disease (CD) and support for the development of a novel companion diagnostic. A secondary objective is the development of a similar vaccine to treat Johne'... Read More
